Article
Heme oxygenase-1 promoter polymorphism is a predictor of disease relapse in pancreatic neuroendocrine tumors.
The Journal of surgical research - 1 Apr 2011
Vashist Yogesh K, Uzunoglu Guentac, Deutsch Lena, Kalinin Viacheslav, Zehler Oliver, Alzadjali Adil, Kutup Asad, Izbicki Jakob R, Yekebas Emre F
Abstract excerpt
BACKGROUND: Current available preoperative diagnostic workup is insufficient to differentiate between benign and malignant pancreatic neuroendocrine tumors (PNET). The aim of the present study was to evaluate the potential prognostic role of the promoter GTn repeat polymorphism (GTn) of the heme oxygenase-1 gene in PNET. METHODS: Tumor, metastasis, corresponding healthy tissue, and peripheral blood leukocyte DNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
